Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DIANE RYDER COUNCE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1417989740
CMS profile
290771
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$161,693.84

447 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 9; records 51–100 of 447 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DIANE RYDER COUNCE

NPI 1417989740 · CMS profile ID 290771

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 9; records 51–100 of 447 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417989740?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DIANE RYDER COUNCE, NPI 1417989740, CMS profile ID 290771. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 447 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417989740?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). DIANE RYDER COUNCE, NPI 1417989740, CMS profile ID 290771. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 9; records 51–100 of 447 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417989740?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
DIANE RYDER COUNCE, NPI 1417989740, CMS profile ID 290771, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 9; records 51–100 of 447 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1417989740?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

447 matching records · $161,693.84 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 447 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 447.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $900.0011/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728420517 CMS
Lilly USA, LLC $900.0011/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728423967 CMS
Lilly USA, LLC $900.0011/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728430833 CMS
Lilly USA, LLC $900.0011/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728434167 CMS
Lilly USA, LLC $900.0011/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728434181 CMS
Neurelis, Inc. $1,400.0011/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751866137 CMS
Neurelis, Inc. $122.1211/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751866139 CMS
UCB, Inc. $14.4011/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746099063 CMS
Allergan, Inc. $11.7711/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533489 CMS
Upsher-Smith Laboratories LLC $9.3511/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 733037587 CMS
Greenwich Biosciences, Inc. $24.5911/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750857171 CMS
SK Life Science, Inc. $16.8611/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 733062027 CMS
Allergan, Inc. $1,920.0011/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533485 CMS
Allergan, Inc. $26.4511/16/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533487 CMS
Amgen Inc. $22.3011/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741008671 CMS
Eisai Inc. $17.7611/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751261483 CMS
Lilly USA, LLC $200.0011/12/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728413767 CMS
Lilly USA, LLC $900.0011/12/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728427373 CMS
Teva Pharmaceuticals USA, Inc. $7.5311/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749531767 CMS
Amneal Pharmaceuticals LLC $17.5411/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719980827 CMS
Allergan, Inc. $18.4011/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533483 CMS
Biogen, Inc. $24.6111/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737257803 CMS
Lundbeck LLC $850.0011/09/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747513511 CMS
Allergan, Inc. $600.0011/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533481 CMS
Lilly USA, LLC $200.0011/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728410441 CMS
Lilly USA, LLC $900.0011/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728427371 CMS
UCB, Inc. $26.6211/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 746106463 CMS
Biogen, Inc. $14.9711/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737257825 CMS
Lilly USA, LLC $900.0011/05/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728420523 CMS
Lilly USA, LLC $900.0011/04/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728427381 CMS
Allergan, Inc. $9.1511/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533479 CMS
Lundbeck LLC $2,720.0011/03/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747513493 CMS
Lundbeck LLC $35.0011/03/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747513497 CMS
Lundbeck LLC $124.9911/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747513503 CMS
Lundbeck LLC $776.2511/03/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747513507 CMS
Assertio Therapeutics, Inc. $23.3711/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748830417 CMS
Allergan, Inc. $600.0010/30/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533477 CMS
SCILEX PHARMACEUTICALS INC. $19.7810/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752404750 CMS
Allergan, Inc. $1,920.0010/29/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533475 CMS
Amgen Inc. $28.6110/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741008667 CMS
Lilly USA, LLC $900.0010/29/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728430821 CMS
Allergan, Inc. $12.7210/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533471 CMS
Allergan, Inc. $600.0010/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533473 CMS
Allergan, Inc. $600.0010/27/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533469 CMS
Teva Pharmaceuticals USA, Inc. $250.0010/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749522599 CMS
Upsher-Smith Laboratories LLC $8.2510/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 733037239 CMS
Alexion Pharmaceuticals, Inc. $17.8010/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726650445 CMS
Allergan, Inc. $1,920.0010/26/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533467 CMS
Allergan, Inc. $600.0010/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723533465 CMS
Lilly USA, LLC $900.0010/22/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728413765 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $153,241.17 397
PY2020 $161,693.84 447
PY2021 $221,783.68 475
PY2022 $174,330.11 396
PY2023 $52,932.66 320
PY2024 $45,705.03 345
PY2025 $85,668.96 283

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $51,974.84 28
PY2024 Principal investigator $226,963.03 60
PY2023 Recipient $11,597.38 5
PY2023 Principal investigator $107,834.07 41
PY2022 Principal investigator $95,889.70 33
PY2021 Recipient $7,000.06 2
PY2021 Principal investigator $18,128.90 8
PY2020 Principal investigator $7,100.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

28 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,545.00 12/31/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
A Phase 3 Multicenter 24-Week Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Atogepant When Added to OnabotulinumtoxinA (BOTOX) for the Preventive Treatment of Chronic Migraine No dispute reported 06/30/2026 1202534935
Principal investigator 1 ABBVIE INC. $1,082.56 12/31/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Upper Limb Essential Tremor No dispute reported 06/30/2026 1202534937
Principal investigator 1 H. Lundbeck A S $3,990.00 07/10/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251772012
Principal investigator 1 ABBVIE INC. $453.72 07/02/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine No dispute reported 06/30/2026 1202496113
Principal investigator 1 H. Lundbeck A S $2,407.00 06/05/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251770767
Principal investigator 1 H. Lundbeck A S $4,228.64 05/15/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251770309
Principal investigator 1 ABBVIE INC. $465.75 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484207
Principal investigator 1 ABBVIE INC. $67.50 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484209
Principal investigator 1 ABBVIE INC. $2,493.45 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484211
Principal investigator 1 ABBVIE INC. $310.50 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484213
Principal investigator 1 ABBVIE INC. $274.20 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484219
Principal investigator 1 ABBVIE INC. $621.00 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484221
Principal investigator 1 ABBVIE INC. $155.25 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484223
Principal investigator 1 ABBVIE INC. $135.00 05/08/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202484225
Principal investigator 1 ABBVIE INC. $2,660.00 05/07/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202482407
Principal investigator 1 ABBVIE INC. $750.00 05/06/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202481189
Principal investigator 1 H. Lundbeck A S $3,713.34 04/28/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769886
Principal investigator 1 PFIZER INC. $999.23 04/24/2025 Non-covered Recipient Entity
Achieve Clinical Research LLC
PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE No dispute reported 06/30/2026 1228777565
Principal investigator 1 H. Lundbeck A S $3,990.00 04/22/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251769780
Principal investigator 1 Sage Therapeutics, LLC $1,670.50 04/17/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
Study to Evaluate SAGE-324 in Participants With Essential Tremors No dispute reported 06/30/2026 1206580577
Principal investigator 1 H. Lundbeck A S $3,990.00 03/19/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251768853
Principal investigator 1 ABBVIE INC. $2,333.45 03/06/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202457860
Principal investigator 1 PFIZER INC. $1,460.50 02/13/2025 Non-covered Recipient Entity
Achieve Clinical Research LLC
PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE No dispute reported 06/30/2026 1228765890
Principal investigator 1 ABBVIE INC. $155.25 02/06/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202449097
Principal investigator 1 Sage Therapeutics, LLC $3,000.00 02/06/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor No dispute reported 06/30/2026 1206580572
Principal investigator 1 H. Lundbeck A S $3,990.00 02/05/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251766959
Principal investigator 1 H. Lundbeck A S $1,400.00 01/07/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, DOSE-FINDING TRIAL OF LU AG09222 FOR THE PREVENTION OF MIGRAINE IN PARTICIPANTS WITH UNSUCCESSFUL PRIOR PREVENTIVE TREATMENTS No dispute reported 06/30/2026 1251766209
Principal investigator 1 ABBVIE INC. $3,633.00 01/02/2025 Non-covered Recipient Entity
ACHIEVE CLINICAL RESEARCH LLC
M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor No dispute reported 06/30/2026 1202435464